Big News: Kit Check Partners with Omnicell to offer BCS

Jenny HarlettBlog

We are very excited to announce that we have entered into an agreement with Omnicell to offer Bluesight for Controlled Substances to Omnicell customers! Through this new partnership, Omnicell customers will have access to a single sign-on dashboard that aggregates information from automated dispensing cabinets and the EMR, documenting who is handling what medications, when, where, and for whom.  This … Read More

Omnicell and Kit Check Partner to Offer Cloud-based Solution for Tracking of Controlled Substances

Jenny HarlettPress Release

Medication intelligence software solution supports critical need for hospitals and health systems to identify drug diversion to combat national opioid crisis MOUNTAIN VIEW, Calif.—December 9, 2019—Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, has entered into an agreement with Kit Check™ to offer Bluesight™ for Controlled Substances diversion prevention software, … Read More

Kit Check Partners with Sandoz to Help Improve Drug Administration Safety

Jenny HarlettBlog

We are thrilled to announce our commercial and supply agreement with Sandoz that will allow Sandoz generic injectable products to operate out of the box in any Kit Check customer site without any additional labor. Kit Check and Sandoz will provide a complete solution for manufacturers and contract manufacturing organizations (CMOs) that want to implement RFID tagging in facilities that … Read More

Kit Check and Sandoz agree to a commercialization collaboration that helps improve hospital medication administration safety

Jenny HarlettPress Release

Implementation of Kit Check RFID technology enables accuracy and visibility of hospital medications, from the production line to the patient Washington DC, June 27, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, along with Sandoz, a Novartis division, today announced a commercialization and supply agreement that will allow Sandoz generic injectable products to operate out … Read More